Prevalence and related drug cost of comorbidities in HIV-infected patients receiving highly active antiretroviral therapy in Taiwan: a cross-sectional study
ConclusionsAmong HIV-infected Taiwanese patients receiving HAART, significant increases in comorbidity prevalence with age, along with rising comorbidity medication costs, suggest the need for preventative as well as chronic care.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research
More News: Allergy & Immunology | Chemistry | Chia | Databases & Libraries | Depression | Diabetes | Diabetes Mellitus | Endocrinology | Gallstones | Health Insurance | Highly Active Antiretroviral Therapy | Hypertension | Insurance | Kidney Stones | Microbiology | Study | Taiwan Health